You take all the time to type that, with no substance or fact relating to anything.
Just the usual scaremongering.
48 million volume is tiny for XPE it has done 200+ million days before.
But most imporantly, if XPE is *that bad* why dont you stop posting in here and move on to greener pastures, make the big bucks, not hang out with the losers?
*crickets*
XPE Charts, page-11293
-
- There are more pages in this discussion • 1,194 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OAK (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.673M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 24381 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 75641 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 24381 | 0.062 |
2 | 20400 | 0.060 |
1 | 82000 | 0.057 |
1 | 55000 | 0.053 |
1 | 100000 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.069 | 75641 | 1 |
0.105 | 1524 | 1 |
0.175 | 22450 | 1 |
0.180 | 30000 | 1 |
0.190 | 29137 | 1 |
Last trade - 16.12pm 10/10/2024 (20 minute delay) ? |
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
OAK (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online